Duck Viral Enteritis: Clinical Signs and Management

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-06-06

Key Takeaways

• Duck Viral Enteritis (DVE), caused by anatid herpesvirus 1 (AnHV-1), is a highly contagious viral disease affecting waterfowl (ducks, geese, swans) with horizontal transmission via direct contact, contaminated water, and fomites.
• Clinical signs range from peracute sudden death to lethargy, anorexia, oculonasal discharge, hemorrhagic diarrhea, and phallus prolapse in males, with morbidity approaching 100% and mortality often exceeding 80% in naive flocks.
• Diagnostic approaches include virus isolation, conventional and real-time PCR for viral DNA detection, serology (ELISA, virus neutralization) for antibody detection, and histopathology for characteristic intranuclear inclusion bodies.
• There is no specific antiviral therapy for DVE; management focuses on supportive care, control of secondary bacterial infections with antibiotics, and strict biosecurity measures including quarantine, depopulation, and disinfection.
• Vaccination with live attenuated vaccines is the primary control strategy, with ongoing development of genetically modified recombinant vaccines for improved safety and efficacy, potentially offering multivalent protection.
• Gross pathological findings are prominent in the gastrointestinal tract (hemorrhagic erosions, pseudomembranes), liver (necrosis, pallor), spleen (splenomegaly), and cloaca (congestion, ulceration).

Introduction and Etiology

Duck viral enteritis (DVE), commonly referred to as duck plague, is an acute, highly contagious viral disease affecting members of the order Anseriformes (ducks, geese, swans) [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. The disease is caused by anatid herpesvirus 1 (AnHV-1), a member of the subfamily Alphaherpesvirinae within the family Herpesviridae [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. The virion possesses a linear double-stranded DNA genome approximately 150-160 kbp in size, enclosed within an icosahedral capsid and a lipid envelope [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>]. Multiple genes have been characterized for their roles in replication, virulence, and immune evasion, including UL50 [<a href="#ref-1">1</a>], UL24 [<a href="#ref-7">7</a>], US3 [<a href="#ref-8">8</a>], UL14 [<a href="#ref-9">9</a>], and LORF4 [<a href="#ref-10">10</a>]. The virus can establish latency in recovered birds, serving as a reservoir for outbreaks [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. The question "what is ducks disease" often refers to DVE as one of the most significant viral pathogens of waterfowl, alongside duck hepatitis virus and Riemerella anatipestifer infection (see Duck Disease: Comprehensive Veterinary Reference on Common Pathogens and Clinical Management).

Epidemiology and Host Range

DVE occurs worldwide in both domestic and wild waterfowl populations [<a href="#ref-2">2</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. Susceptible species include mallards (Anas platyrhynchos), Pekin ducks, Muscovy ducks, geese, and swans [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>]. Outbreaks in vaccinated flocks have been reported, indicating antigenic drift or insufficient immune coverage [<a href="#ref-4">4</a>, <a href="#ref-11">11</a>]. Transmission occurs horizontally via direct contact, contaminated water, fomites, and ingestion of infected material [<a href="#ref-16">16</a>, <a href="#ref-18">18</a>]. The virus is shed in feces, oral secretions, and on feathers [<a href="#ref-17">17</a>, <a href="#ref-19">19</a>]. Vertical transmission is not considered significant [<a href="#ref-15">15</a>]. Wild birds can act as asymptomatic carriers and introduce the virus into naive domestic flocks [<a href="#ref-13">13</a>]. Outbreaks in zoo collections have been documented, such as an Australian black swan (Cygnus atratus) flock in Bangladesh [<a href="#ref-14">14</a>]. The incubation period ranges from 3 to 7 days in natural infections but may extend to 14 days under experimental conditions [<a href="#ref-3">3</a>, <a href="#ref-20">20</a>]. Environmental persistence is favored by cool, moist conditions; the lipid envelope renders the virus susceptible to common disinfectants [<a href="#ref-18">18</a>, <a href="#ref-21">21</a>]. A variant with a deletion in UL2 has been described, showing altered pathogenicity and tissue tropism [<a href="#ref-3">3</a>, <a href="#ref-5">5</a>]. The disease is economically important due to high mortality, reduced egg production, and trade restrictions [<a href="#ref-4">4</a>, <a href="#ref-22">22</a>].

Clinical Signs

The clinical presentation of DVE varies with virus strain, host age, immune status, and species [<a href="#ref-12">12</a>, <a href="#ref-23">23</a>]. Peracute infections cause sudden death with few premonitory signs, often within 24-48 hours of exposure [<a href="#ref-4">4</a>, <a href="#ref-14">14</a>]. In acute cases, affected birds exhibit the following signs:

• Lethargy, drooping wings, and reluctance to move [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>].
• Anorexia and polydipsia [<a href="#ref-20">20</a>, <a href="#ref-26">26</a>].
• Oculonasal discharge, often serous to purulent [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>].
• Photophobia and conjunctivitis [<a href="#ref-7">7</a>, <a href="#ref-27">27</a>].
• Diarrhea, initially watery then becoming hemorrhagic [<a href="#ref-1">1</a>, <a href="#ref-11">11</a>].
• Cyanosis of the bill and comb (in waterfowl with combs) [<a href="#ref-28">28</a>, <a href="#ref-29">29</a>].
• Prolapse of the phallus in male ducks [<a href="#ref-14">14</a>, <a href="#ref-22">22</a>].
• Ataxia and head tremors in later stages [<a href="#ref-3">3</a>, <a href="#ref-30">30</a>].
• Reduced egg production with misshapen or thin-shelled eggs [<a href="#ref-19">19</a>, <a href="#ref-31">31</a>].

Morbidity can approach 100% in naive flocks, and mortality often exceeds 80% without intervention [<a href="#ref-4">4</a>, <a href="#ref-12">12</a>, <a href="#ref-23">23</a>]. Recovered birds may shed virus intermittently for months [<a href="#ref-11">11</a>, <a href="#ref-32">32</a>]. Chronic infections may present with emaciation and persistent diarrhea [<a href="#ref-10">10</a>, <a href="#ref-26">26</a>].

Pathological Findings

Gross lesions are most prominent in the gastrointestinal tract, lymphoid tissues, and liver [<a href="#ref-1">1</a>, <a href="#ref-17">17</a>, <a href="#ref-25">25</a>]. Typical necropsy findings include:

• Gastrointestinal tract: Hemorrhagic erosions and pseudomembranous plaques in the esophagus, crop, and small intestine [<a href="#ref-11">11</a>, <a href="#ref-29">29</a>, <a href="#ref-33">33</a>]. The intestinal lumen may contain blood-tinged fluid [<a href="#ref-4">4</a>, <a href="#ref-26">26</a>].
• Liver: Enlargement, pallor, and multiple pale necrotic foci 1-3 mm in diameter [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>, <a href="#ref-14">14</a>]. Petechial hemorrhages on the capsule are common [<a href="#ref-17">17</a>, <a href="#ref-20">20</a>].
• Spleen: Splenomegaly with mottled appearance [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>, <a href="#ref-12">12</a>].
• Heart: Epicardial petechiae and myocardial pallor in severe cases [<a href="#ref-5">5</a>, <a href="#ref-23">23</a>].
• Cloaca: Severe congestion, ulceration, and diphtheritic membranes [<a href="#ref-18">18</a>, <a href="#ref-28">28</a>].
• Lymphoid tissues: Hemorrhagic lesions in bursa of Fabricius and thymus [<a href="#ref-16">16</a>, <a href="#ref-31">31</a>].

Histologically, lesions are characterized by necrosis of epithelial cells and hepatocytes with intranuclear eosinophilic inclusion bodies (Cowdry type A) in affected tissues [<a href="#ref-1">1</a>, <a href="#ref-25">25</a>, <a href="#ref-27">27</a>]. Viral antigen can be demonstrated by immunohistochemistry [<a href="#ref-21">21</a>, <a href="#ref-24">24</a>]. The disease induces apoptosis in intestinal epithelial cells, and treatment with poly I:C has been shown to alleviate intestinal injury by inhibiting apoptosis in experimental models [<a href="#ref-26">26</a>]. Proteomic studies have revealed that viral protein VP26 interacts with the host actin-myosin II network to regulate virus proliferation [<a href="#ref-25">25</a>].

Diagnostic Approaches

Rapid and accurate diagnosis of DVE is essential for outbreak control [<a href="#ref-21">21</a>, <a href="#ref-24">24</a>]. Diagnostic methods are summarized in Table 1.

Table 1. Diagnostic methods for duck viral enteritis.

A diagnostic workflow is presented in Figure 1.

flowchart TD
 A["Clinical suspicion of DVE"] --> B["Collect samples: cloacal swab, liver, spleen, intestine"]
 B --> C{"Rapid screening"}
 C -->|"MIRA or RPA positive"| D["Presumptive DVE positive; initiate control measures"]
 C -->|"PCR or qPCR positive"| D
 C -->|"Negative"| E["Consider other pathogens"]
 D --> F["Confirmatory testing: virus isolation or genome sequencing"]
 F --> G["Genotype characterization"]
 E --> H["Differential diagnoses: duck hepatitis, avian influenza, Riemerella anatipestifer, fowl cholera"]
 H --> I["Further laboratory testing as needed"]

Differential diagnoses must exclude other causes of acute mortality and enteritis in waterfowl, including duck viral hepatitis, highly pathogenic avian influenza (see Highly Pathogenic Avian Influenza (H5N1) in Poultry and Wild Birds: Clinical Signs, Transmission Dynamics, and Surveillance Maps), fowl cholera (Fowl Cholera in Poultry: Pasteurella Multocida Pathogenesis, Clinical Signs, and Outbreak Management), Riemerella anatipestifer infection, necrotic enteritis (Necrotic Enteritis in Poultry: Clostridium perfringens Infection, Diagnosis, and Prevention), and salmonellosis (Salmonella in Chickens: Etiology, Epidemiology, Clinical Signs, Pathology, Diagnostics, Treatment, and Control) [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>, <a href="#ref-13">13</a>, <a href="#ref-17">17</a>].

Treatment and Management

No specific antiviral therapy is approved for DVE in waterfowl [<a href="#ref-18">18</a>, <a href="#ref-26">26</a>]. Supportive care includes provision of clean water, nutritional support, and reduction of stress [<a href="#ref-1">1</a>, <a href="#ref-33">33</a>]. Antibiotic therapy may be indicated to control secondary bacterial infections [<a href="#ref-11">11</a>, <a href="#ref-29">29</a>]. Piperazine has been investigated in vitro for its antiviral activity against AnHV-1, potentially by modulating host cytokine responses, but clinical application requires further validation [<a href="#ref-18">18</a>]. Chlorogenic acid has shown inhibitory effects in duck embryo fibroblasts infected with duck plague virus in transcriptomic studies [<a href="#ref-33">33</a>]. The use of poly I:C as an immunomodulator has been explored to reduce intestinal apoptosis [<a href="#ref-26">26</a>].

Management of an outbreak involves immediate quarantine of affected premises, depopulation of severely affected flocks, and thorough cleaning and disinfection [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>, <a href="#ref-32">32</a>]. Carcasses should be disposed of by incineration or deep burial [<a href="#ref-4">4</a>, <a href="#ref-19">19</a>]. Movement restrictions on waterfowl and equipment should be enforced [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>].

Control and Prevention

Vaccination is the cornerstone of DVE control [<a href="#ref-32">32</a>]. Live attenuated vaccines derived from chicken embryo fibroblasts have been used successfully for decades [<a href="#ref-19">19</a>, <a href="#ref-23">23</a>, <a href="#ref-31">31</a>]. However, vaccine failures have been documented due to the emergence of virulent strains [<a href="#ref-4">4</a>]. Genetically modified recombinant vaccines are under development using CRISPR/Cas9 editing to insert foreign genes or delete virulence factors, improving safety and efficacy [<a href="#ref-11">11</a>, <a href="#ref-31">31</a>, <a href="#ref-34">34</a>, <a href="#ref-35">35</a>]. For example, deletion of the ICP27 gene or combination gene deletions have been shown to enhance safety and restore gut microbiota balance [<a href="#ref-11">11</a>, <a href="#ref-31">31</a>]. Recombinant DVE vectors expressing antigens from duck hepatitis A virus, Pasteurella multocida, influenza virus, Chlamydia psittaci, and goose astrovirus have been constructed and evaluated, demonstrating potential for multivalent protection [<a href="#ref-20">20</a>, <a href="#ref-22">22</a>, <a href="#ref-28">28</a>, <a href="#ref-30">30</a>, <a href="#ref-34">34</a>, <a href="#ref-35">35</a>]. Tissue tropism of these recombinant vaccines has been assessed in day-old chickens, indicating minimal horizontal transmission [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. The UL50 gene is essential for viral replication and pathogenesis, making it a target for attenuation [<a href="#ref-1">1</a>]. The UL2 gene deletion has been associated with reduced pathogenicity while retaining immunogenicity [<a href="#ref-3">3</a>, <a href="#ref-5">5</a>].

Biosecurity measures include all-in-all-out flock management, segregation of waterfowl species, disinfection of water sources, and control of wild bird access to domestic flocks [<a href="#ref-13">13</a>, <a href="#ref-19">19</a>]. In areas where DVE is endemic, routine vaccination of breeding stock and growing ducklings is recommended [<a href="#ref-23">23</a>, <a href="#ref-32">32</a>]. Surveillance using molecular and serological methods is advised for early detection [<a href="#ref-21">21</a>, <a href="#ref-24">24</a>, <a href="#ref-28">28</a>]. Comprehensive management protocols are further detailed in Duck Viral Enteritis (Duck Plague): Clinical Signs and Control and Duck Viral Enteritis: Clinical Disease and Management.

References

Related Clinical & Scientific Guides

• Duck Diseases: A Comprehensive Overview for Veterinary Practitioners
• Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact
• Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs